Viberzi is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Eluxadoline.
| Product ID | 61874-075_0ad2e4fc-955d-41f7-a2ae-45e92b6bcefd |
| NDC | 61874-075 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Viberzi |
| Generic Name | Eluxadoline |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-10-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA206940 |
| Labeler Name | Allergan, Inc. |
| Substance Name | ELUXADOLINE |
| Active Ingredient Strength | 75 mg/1 |
| Pharm Classes | Opioid mu-Receptor Agonists [MoA], mu-Opioid Receptor Agonist [EPC] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2015-10-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA206940 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-10-01 |
| Marketing Category | NDA |
| Application Number | NDA206940 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-10-01 |
| Ingredient | Strength |
|---|---|
| ELUXADOLINE | 75 mg/1 |
| SPL SET ID: | 7821bd40-4c84-4984-951b-6436ae20421a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 61874-075 | Viberzi | Eluxadoline |
| 61874-100 | Viberzi | Eluxadoline |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VIBERZI 86803941 4982924 Live/Registered |
ALLERGAN HOLDINGS UNLIMITED COMPANY 2015-10-29 |
![]() VIBERZI 86481014 4928665 Live/Registered |
ALLERGAN HOLDINGS UNLIMITED COMPANY 2014-12-15 |